Sulfanegen stimulates 3-mercaptopyruvate sulfurtransferase activity and ameliorates Alzheimer's disease pathology and oxidative stress in vivo is a research paper published in Redox Biology (2022). On theSindex it has a DataRank of 0. It has been cited 29 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01-AG062469
National Institute of Health
Grant: R01-NS108686
National Institute of Health
Grant: RF1-AG062135
NIA NIH HHS
Grant: R01 AG062469
National Institutes of Health
Grant: 5R01AG062469-02
Role of glyoxalase-1 in Alzheimer's disease pathogenesis and therapy
National Institutes of Health
Grant: 5R01NS108686-05
Tau-dependent cognitive deficits in alpha-synucleinopathies
National Institutes of Health
Grant: 1RF1AG062135-01
AMP-Kinase as a target for neuroprotection in AD
University of Minnesota
University of Minnesota Center for Drug Design
FWCI
3.11
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals